Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.



The PREVENA RESTOR AXIO•FORM Incision Management System delivers negative pressure wound therapy designed to manage post-operative incisions, as well as the surrounding soft tissue envelope. PREVENA RESTOR AXIO•FORM System helps stabilize the incision and surrounding soft tissue, reduce edema, and helps enhance post-operative recovery. This is the third offering in the PREVENA RESTOR Therapy portfolio, launched in 2019, to optimize post-surgical care and expand the company’s specialty surgical offerings. Please refer to the PREVENA RESTOR AXIO•FORM System Instructions For Use for important safety information.

NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.



Submit a Comment

Your email address will not be published. Required fields are marked *